Ftse Mib
33.311,37
1,23%
DAX
18.131,97
0,32%
S&P 500
5.482,57
0,17%
NASDAQ
17.852,57
-0,02%
Bitcoin
64.642,86
-2,77%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Graphite Bio Inc (GRPH) Graphite Bio Inc (GRPH) Notizie

GRPH

Graphite Bio (GRPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GRPH
DataOraFonteTitoloSimboloCompagnia
08/03/202423:17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GRPHGraphite Bio Inc
08/03/202423:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
08/03/202423:00Business WireGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsNASDAQ:GRPHGraphite Bio Inc
27/02/202422:11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GRPHGraphite Bio Inc
13/02/202422:44Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GRPHGraphite Bio Inc
09/02/202423:23Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:GRPHGraphite Bio Inc
05/02/202422:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRPHGraphite Bio Inc
06/12/202322:57Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:GRPHGraphite Bio Inc
15/11/202313:00Business WireLENZ Therapeutics and Graphite Bio Announce Merger AgreementNASDAQ:GRPHGraphite Bio Inc
13/09/202322:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:GRPHGraphite Bio Inc
14/08/202323:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRPHGraphite Bio Inc
21/07/202323:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRPHGraphite Bio Inc
23/06/202313:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
23/06/202313:00Business WireGraphite Bio Announces Departure of Chief Financial OfficerNASDAQ:GRPHGraphite Bio Inc
06/06/202322:16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:GRPHGraphite Bio Inc
06/06/202322:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GRPHGraphite Bio Inc
11/05/202322:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GRPHGraphite Bio Inc
20/03/202321:18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GRPHGraphite Bio Inc
20/03/202321:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GRPHGraphite Bio Inc
20/03/202321:05Business WireGraphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
22/02/202322:05Business WireGraphite Bio Announces Process to Explore Strategic Alternatives and Corporate RestructuringNASDAQ:GRPHGraphite Bio Inc
05/01/202322:05Business WireGraphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell DiseaseNASDAQ:GRPHGraphite Bio Inc
12/12/202214:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GRPHGraphite Bio Inc
11/12/202216:00Business WireGraphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual MeetingNASDAQ:GRPHGraphite Bio Inc
21/11/202214:00Business WireGraphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx ConferenceNASDAQ:GRPHGraphite Bio Inc
14/11/202205:05TipRanksBTIG Sticks to Their Buy Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
14/11/202204:55TipRanksSVB Securities Sticks to Its Buy Rating for Graphite Bio (GRPH)NASDAQ:GRPHGraphite Bio Inc
11/11/202202:49TipRanksGraphite Bio (GRPH) Receives a Hold from RBC CapitalNASDAQ:GRPHGraphite Bio Inc
09/11/202222:05Business WireGraphite Bio Reports Recent Business Progress and Third Quarter 2022 Financial ResultsNASDAQ:GRPHGraphite Bio Inc
03/11/202214:05Business WireGraphite Bio Announces Abstracts Accepted for Upcoming 64th ASH Annual Meeting and ExpositionNASDAQ:GRPHGraphite Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GRPH

La tua Cronologia

NYSE
AB
AllianceBernstein
BIT
P227U2
NLBNPIT227U2 20240918 16...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network